Premium
Fractional CO 2 laser‐assisted topical rifamycin drug delivery in the treatment of pediatric cutaneous leishmaniasis
Author(s) -
Lodi Giuseppe,
Sannino Mario,
Caterino Paolo,
Cannarozzo Giovanni,
Bennardo Luigi,
Nisticò Steven Paul
Publication year - 2021
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14608
Subject(s) - medicine , rifamycin , cutaneous leishmaniasis , dermatology , leishmaniasis , drug , pharmacology , antibiotics , immunology , microbiology and biotechnology , biology
Abstract Cutaneous leishmaniasis is challenging to treat. Various drugs have been proposed to manage this condition, with variable results. In this case report, we describe laser‐assisted delivery of rifamycin to treat this infection. Two sessions of fractional CO 2 laser were performed one month apart. Each was followed by a topical application of rifamycin for three days. Resolution with minimal scarring was obtained, suggesting this technique might be safe and effective in treating cutaneous leishmaniasis.